维莫德吉治疗基底细胞痣综合征所致顽固性腹泻的特征分析 - Suppr

Suppr

超能文献

Characterization of intractable diarrhea resulting from vismodegib treatment for basal cell nevus syndrome.

作者信息

Patel Ashmi, Salah Haneen T, Hamel Remi K, Hall Elizabeth L, Crumley Suzanne M, Woods Karen L, Goldberg Leonard H

机构信息

Texas A&M College of Medicine, Houston Methodist Hospital, Houston, Texas.

Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas.

出版信息

JAAD Case Rep. 2022 Aug 4;31:72-75. doi: 10.1016/j.jdcr.2022.07.030. eCollection 2023 Jan.

DOI:10.1016/j.jdcr.2022.07.030

PMID:36545486

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9761328/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8937/9761328/5a63b9cdf54b/gr1.jpg

相似文献

Characterization of intractable diarrhea resulting from vismodegib treatment for basal cell nevus syndrome.维莫德吉治疗基底细胞痣综合征所致顽固性腹泻的特征分析

JAAD Case Rep. 2022 Aug 4;31:72-75. doi: 10.1016/j.jdcr.2022.07.030. eCollection 2023 Jan.

Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: final results from the multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.基底细胞痣综合征患者中 hedgehog 通路的抑制：多中心、随机、双盲、安慰剂对照、2 期临床试验的最终结果。

Lancet Oncol. 2016 Dec;17(12):1720-1731. doi: 10.1016/S1470-2045(16)30566-6. Epub 2016 Nov 10.

Vismodegib hedgehog-signaling inhibition and treatment of basal cell carcinomas as well as keratocystic odontogenic tumors in Gorlin syndrome.维莫德吉抑制Hedgehog信号通路及治疗基底细胞癌和戈林综合征中的牙源性角化囊性瘤。

Ann Maxillofac Surg. 2015 Jan-Jun;5(1):14-9. doi: 10.4103/2231-0746.161049.

Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib.晚期基底细胞癌患者接受 Hedgehog 通路抑制剂维莫德吉治疗的扩大准入研究。

J Am Acad Dermatol. 2014 Jan;70(1):60-9. doi: 10.1016/j.jaad.2013.09.012. Epub 2013 Nov 1.

Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome: pooled analysis of two trials.维莫德吉治疗基底细胞痣综合征患者的安全性和有效性：两项试验的汇总分析

Orphanet J Rare Dis. 2016 Sep 1;11(1):120. doi: 10.1186/s13023-016-0506-z.

Long-term Response to Vismodegib in a Patient with Gorlin-Goltz Syndrome: A Case Report and Review of Pathological Mechanisms Involved.一名戈林-戈尔茨综合征患者对维莫德吉的长期反应：病例报告及相关病理机制综述

Cureus. 2019 Aug 13;11(8):e5383. doi: 10.7759/cureus.5383.

Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial.维莫德吉治疗晚期基底细胞癌患者：国际开放标签试验STEVIE的初步分析

Eur J Cancer. 2017 Nov;86:334-348. doi: 10.1016/j.ejca.2017.08.022. Epub 2017 Nov 5.

Vismodegib for the treatment of basal cell carcinoma: results and implications of the ERIVANCE BCC trial.维莫德吉治疗基底细胞癌：ERIVANCE BCC试验的结果及意义

Future Oncol. 2014 May;10(6):927-36. doi: 10.2217/fon.14.50.

Increased Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma.维莫德吉治疗基底细胞癌后皮肤鳞状细胞癌风险增加。

JAMA Dermatol. 2016 May 1;152(5):527-32. doi: 10.1001/jamadermatol.2015.4330.

Predictive factors of response to vismodegib: a French study of 61 patients with multiple or locally advanced basal cell carcinoma.维莫德吉治疗反应的预测因素：一项针对 61 例多发性或局部晚期基底细胞癌患者的法国研究。

Eur J Dermatol. 2022 May 1;32(3):401-407. doi: 10.1684/ejd.2022.4264.

引用本文的文献

Personalized Systemic Therapies in Hereditary Cancer Syndromes.遗传性癌症综合征中的个体化系统治疗。

Genes (Basel). 2023 Mar 9;14(3):684. doi: 10.3390/genes14030684.

本文引用的文献

Key Clinical Adverse Events in Patients with Advanced Basal Cell Carcinoma Treated with Sonidegib or Vismodegib: A Post Hoc Analysis.使用索尼德吉或维莫德吉治疗的晚期基底细胞癌患者的关键临床不良事件：一项事后分析

Dermatol Ther (Heidelb). 2021 Oct;11(5):1839-1849. doi: 10.1007/s13555-021-00588-8. Epub 2021 Sep 6.

Immunotherapy for Non-melanoma Skin Cancer.非黑色素瘤皮肤癌的免疫疗法。

Curr Oncol Rep. 2021 Aug 27;23(11):125. doi: 10.1007/s11912-021-01120-z.

Managing adverse effects by dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor vismodegib: a single centre experience.在使用刺猬信号通路抑制剂维莫德吉对局部晚期基底细胞癌进行常规治疗期间，通过降低剂量来管理不良反应：一项单中心经验。

J Eur Acad Dermatol Venereol. 2019 Apr;33(4):e144-e145. doi: 10.1111/jdv.15367. Epub 2018 Dec 17.

Sonic hedgehog signaling controls gut epithelium homeostasis following intestinal ischemia-reperfusion in a rat.音猬因子信号通路在大鼠肠缺血再灌注后调控肠道上皮稳态。

Pediatr Surg Int. 2019 Feb;35(2):255-261. doi: 10.1007/s00383-018-4406-2. Epub 2018 Nov 1.

Guidelines of care for the management of basal cell carcinoma.《基底细胞癌治疗管理指南》。

J Am Acad Dermatol. 2018 Mar;78(3):540-559. doi: 10.1016/j.jaad.2017.10.006. Epub 2018 Jan 10.

Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study.维莫德吉治疗晚期基底细胞癌患者的长期安全性和有效性：关键ERIVANCE BCC研究的最终更新

BMC Cancer. 2017 May 16;17(1):332. doi: 10.1186/s12885-017-3286-5.

Lancet Oncol. 2016 Dec;17(12):1720-1731. doi: 10.1016/S1470-2045(16)30566-6. Epub 2016 Nov 10.

An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinoma.一项研究者发起的、开放性标签的、维莫德吉作为高风险基底细胞癌手术新辅助治疗的临床试验。

J Am Acad Dermatol. 2014 Nov;71(5):904-911.e1. doi: 10.1016/j.jaad.2014.05.020. Epub 2014 Jun 11.

J Am Acad Dermatol. 2014 Jan;70(1):60-9. doi: 10.1016/j.jaad.2013.09.012. Epub 2013 Nov 1.

Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome.抑制基底细胞痣综合征患者的 hedgehog 通路。

N Engl J Med. 2012 Jun 7;366(23):2180-8. doi: 10.1056/NEJMoa1113538.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验